Kelly Gardner

Title: Innovator Spotlight: Kelly Gardner

Introduction: Kelly Gardner, an accomplished inventor based in Berkeley, California, has made significant contributions to the field of biological assay technology. With a background in developing innovative systems for electrophoretic separation and analysis of analytes, Gardner holds two patents that showcase her expertise and creativity in scientific solutions.

Latest Patents: Kelly Gardner's most notable patents include advanced systems for assaying biological samples for target analytes. The first patent details a system featuring an assaying device and a computer controller. This device comprises a housing with a receptacle designed to accept an electrophoresis cell. The electrophoresis cell features a recess area for a chip that is capable of accommodating biological samples. Notably, this chip incorporates a polymeric separation medium that possesses activatable functional groups, which bond covalently to target analytes when activated by a designated source of activation energy. The computer controller is directly connected to the activation energy source to facilitate the activation process, allowing for precise application of energy to the polymeric medium.

The second patent showcases similar technology and contributes to the field by refining the methods of electrophoretic separation and analysis, emphasizing the importance of efficient and accurate biological testing.

Career Highlights: Kelly Gardner is currently employed at ProteinSimple, a leader in the development of protein analysis technologies. Her work at the company has been pivotal in enhancing assay techniques, solidifying her reputation as an innovator in her field. With a keen focus on electrophoretic technologies, Gardner continues to advance scientific understanding and application in biological testing.

Collaborations: Throughout her career, Kelly has collaborated with notable colleagues such as Joshua I. Molho and Danh C. Tran. These partnerships have allowed for the pooling of expertise and resources, leading to the development of cutting-edge technologies that shape the future of biological analysis.

Conclusion: Kelly Gardner exemplifies the spirit of innovation through her significant contributions to electrophoretic technology. With her two patents, extensive experience at ProteinSimple, and collaborations with esteemed colleagues, she continues to drive forward advancements in biological assay methodologies. As a trailblazer in her field, Gardner sets a strong precedent for aspiring inventors and emphasizes the impact of dedicated research and innovation on the scientific community.